The Juicy Byte
juicybyte.substack.com
The Juicy Byte
@juicybyte.substack.com
I write a substack called The Juicy Byte featuring CPG insights mixed with science.
I have a Ph.D in flavor chemistry and worked in big CPG.
If you’re into the edges of consumer health, wellness, biotech, and beauty—
The Juicy Byte breaks it down weekly, with stats, science, and skepticism.

Subscribe here → juicybyte.substack.com/p/191-what-i...
Let me know what trend you’re watching right now.
191 - What I'm Reading: Week of April 11th.
Glossier’s valuation hits reset, saccharin might save your antibiotics, the person overseeing eye drop safety is out, skincare is sneaking into makeup (and pet treats), a €445 toner & more...
juicybyte.substack.com
April 11, 2025 at 2:33 PM
Also inside this week’s issue:
• The rise of cycle-syncing femtech
• TikTok’s influence on “ice face bath” interest (hi Utah)
• A €445 toner launch that’s practically performance art
• Supplements built around colostrum, paraxanthine, and vibes
April 11, 2025 at 2:33 PM
Pet care is going through a DTC design glow-up.
Rigby Pets (functional snacks in human-grade packaging) looks more Erewhon than PetSmart.
I almost ate one by accident. Not kidding.
April 11, 2025 at 2:33 PM
Women’s health VC surged 55% in 2024, totaling $2.6B.
But here’s what’s interesting: biopharma is catching up to healthtech—now 35% of total investment.

This shift signals a deeper science wave ahead for the category.
April 11, 2025 at 2:33 PM
Saccharin—yes, the sweetener—might have antibiotic-enhancing effects.
It weakens bacterial membranes and interferes with DNA repair.
The future of antibiotics might be… artificial sweeteners?

Biotech x pantry ingredients is becoming a theme.
April 11, 2025 at 2:33 PM
Meanwhile, eye drop safety is in limbo.
The FDA’s top expert responsible for preventing contamination (yes, that issue behind dozens of recalls) was just let go.

2023–2024 saw 27 eye drop recalls. The largest tied to one manufacturer.
Now? A gray zone.
April 11, 2025 at 2:33 PM
Glossier is reportedly raising at half its 2021 valuation.
That’s not failure—it’s right-sizing.

Back then, the brand positioned itself as tech-meets-beauty. Today, it’s back to product: retail, fragrance, and core identity.
This makes it acquirable, not broken.
April 11, 2025 at 2:33 PM
📊 A study of 44M lab tests shows some postpartum biomarkers take up to a year to normalize (no, bodies don’t "bounce back"). www.science.org/doi/10.1126/...
@science.org
Pregnancy and postpartum dynamics revealed by millions of lab tests
Analysis of 300,000 pregnancies shows detailed physiological changes at weekly resolution in health and complications.
www.science.org
March 28, 2025 at 3:03 PM
🎨 Gen Alpha is obsessed with color, and it’s reshaping packaging strategies.
www.businessoffashion.com/articles/bea...
@businessoffashion.com.web.brid.gy
(someone bring back Hard Candy rings...please!)
March 28, 2025 at 3:03 PM